Fidelity Investments’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8K | Hold |
|
|||||
|
2025
Q1 | $62.7K | Sell |
|
|||||
|
2024
Q4 | $134K | Buy |
|
|||||
|
2024
Q3 | $251K | Buy |
|
|||||
|
2024
Q2 | $223K | Buy |
|
|||||
|
2024
Q1 | $205K | Sell |
|
|||||
|
2023
Q4 | $3.87M | Sell |
|
|||||
|
2023
Q3 | $20.8M | Buy |
|
|||||
|
2023
Q2 | $32.4M | Buy |
|
|||||
|
2023
Q1 | $29M | Buy |
|
|||||
|
2022
Q4 | $36.1M | Sell |
|
|||||
|
2022
Q3 | $57.5M | Buy |
|
|||||
|
2022
Q2 | $28M | Sell |
|
|||||
|
2022
Q1 | $53.6M | Buy |
|
|||||
|
2021
Q4 | $95.5M | Buy |
|
|||||
|
2021
Q3 | $184M | Buy |
|
|||||
|
2021
Q2 | $127M | Sell |
|
|||||
|
2021
Q1 | $163M | Sell |
|
|||||
|
2020
Q4 | $270M | Buy |
|
|||||
|
2020
Q3 | $173M | Buy |
|